Cullinan’s CLN-978 Shows Deep B-Cell Depletion and Remissions in Lupus and RA

Cullinan Therapeutics’ CLN-978 T-cell engager showed deep B-cell depletion and clinical remissions in hard-to-treat lupus and rheumatoid arthritis patients after a single dose at EULAR 2026.